Skip to main content

Table 1 Patient characteristics

From: Differentially methylated regions in T cells identify kidney transplant patients at risk for de novo skin cancer

  cSCC Non-cSCC  
  N = 27 N = 27  
Age (years)a 61.7 (27–77) 61.3 (27–77) p = 0.802
Gender (male) 19 (70.4%) 19 (70.4%) p = 1
Years between Tx and first cSCCa 5.4 (0.9–12.5)
CMV status    p = 0.46
 Negative 12 (44.4%) 9 (33.3%)  
 Positive 15 (55.6%) 17 (63.0%)  
 Unknown 1 (3.7%)  
Dialysis pre-transplantation    p = 0.783
 Yes 16 (59.3%) 15 (55.6%)  
 No 11 (40.7%) 12 (44.4%)  
ESRD diagnosis    p = 0.058
 Polycystic kidney 6 (22.2%) 1 (3.7%)  
 Hypertension 6 (22.2%) 3 (11.1%)  
 Diabetic nefropathy 1 (3.7%) 6 (22.2%)  
 Glomerulonefritis 3 (11.1%) 6 (22.2%)  
 Other 11 (40.7%) 11 (40.7%)  
% CD3a 97.4 (92.4–99.5) 98.0 (95.1–99.5) p = 0.225
% CD4a 73.0 (45.1–91.4) 60.3 (34.8–80.7) p = 0.000
% CD8a 20.7 (5.8–46.2) 32.8 (14.8–60.6) p = 0.000
  1. aMedian and range
  2. cSCC cutaneous squamous cell carcinoma, CMV cytomegalovirus, ESDR end-stage renal disease